The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
| Huvudupphovsmän: | , , , , , , |
|---|---|
| Övriga upphovsmän: | |
| Materialtyp: | Conference item |
| Språk: | English |
| Publicerad: |
Elsevier
2020
|